Researchers & Healthcare Professionals

Mantle Cell Lymphoma - Update on Treatment

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: April 3, 2014
CE  Credit Available Until: December 2, 2015
Time: 1:00 p.m. - 2:00 p.m. ET
Location: Telephone/Web
Target Audience: Oncology nurses and social workers involved in the treatment of patients with mantle cell lymphoma.
View: Program Slides
Read: Transcript
Listen: Presentation | Q&A Session
Access: Virtual Lecture

Activity Purpose

To educate oncology nurses and social workers about treatment for mantle cell lymphoma.

Educational Objectives

At the conclusion of this program, participants should be able to:

  • Identify how mantle cell lymphoma (MCL) is diagnosed
  • Describe current and emerging therapies for individuals living with MCL 
  • Discuss symptom and side effects management of MCL 
  • Explain the role of clinical trials in the continuing improvement of MCL treatment
  • Discuss the importance of patient-provider communication


Brad S. Kahl, MD
Associate Professor of Medicine
Director of Lymphoma Service
University of Wisconsin
Carbone Cancer Center
Madison, WI

Sponsors and Supporters

This activity was made possible by support from Celgene Corporation, Millennium: The Takeda Oncology Company, and Pharmacyclics, Inc. and Janssen Biotech, Inc.

last updated on Monday, June 23, 2014